<- S. H. Duncan, Rowett Inst. Nutrition and Health, Aberdeen, United Kingdom <- H. J. Flint, Rowett Inst. Nutrition and Health, Aberdeen, United Kingdom; 17
特征特性
There are NO known Nagoya Protocol restrictions for this strain.
培養(yǎng)基
KDM110:蛋白瘤胃球菌培養(yǎng)基基礎(chǔ)(DSMZ Medium 436)
KDM215:DSMZ#436加瘤胃液(2%),加1克/升麥芽糖